Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479-80:672-86.
Hadziyannis SJ, Vassilopoulos D, Hadziyannis E. The natural course of chronic hepatitis B virus infection and its management. Adv. Pharmacol 2013;67:247-91.
Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 2000;191:1269-80.
Sprengers D, Janssen HL. Immunomodulatory therapy for chronic hepatitis B virus infection. Fund. Clin. Pharmacol. 2005; 19:17-26.
Akbar SM, Al-Mahtab M, Khan MS. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides. Expert Opin Biol Ther. 2013;13:1063-74.
Akbar SM, Al-Mahtab M, Jahan M, Yoshida O, Hiasa Y. Novel insights into immunotherapy for hepatitis B patients. Expert Rev Gastroenterol Hepatol. 2016;10:267-76.